Search by Drug Name or NDC
NDC 00338-1009-02 Dopamine Hydrochloride and Dextrose 320 mg/100mL Details
Dopamine Hydrochloride and Dextrose 320 mg/100mL
Dopamine Hydrochloride and Dextrose is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is DOPAMINE HYDROCHLORIDE.
Product Information
| NDC | 00338-1009 |
|---|---|
| Product ID | 0338-1009_7b01149c-feae-46bd-94cb-207bcd24ae59 |
| Associated GPIs | 31350020112030 |
| GCN Sequence Number | 004976 |
| GCN Sequence Number Description | dopamine HCl in dextrose 5 % PLAST. BAG 800MG/.25L INTRAVEN |
| HIC3 | J5A |
| HIC3 Description | ADRENERGIC AGENTS,CATECHOLAMINES |
| GCN | 74975 |
| HICL Sequence Number | 002059 |
| HICL Sequence Number Description | DOPAMINE HCL IN DEXTROSE 5 % IN WATER |
| Brand/Generic | Generic |
| Proprietary Name | Dopamine Hydrochloride and Dextrose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dopamine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 320 |
| Active Ingredient Units | mg/100mL |
| Substance Name | DOPAMINE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Catecholamine [EPC], Catecholamines [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019615 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1009-02 (00338100902)
| NDC Package Code | 0338-1009-02 |
|---|---|
| Billing NDC | 00338100902 |
| Package | 18 BAG in 1 CARTON (0338-1009-02) / 250 mL in 1 BAG |
| Marketing Start Date | 1987-03-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |